We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Growing Long-Term Use of LVADs

By HospiMedica staff writers
Posted on 16 Nov 2004
The success of long-term implantable left ventricular-assist devices (LVADs) has led to their increased use in patients previously thought to be unsuitable for mechanical support.

A study published in the September-October 2004 issue of the Journal of Cardiac Surgery documents this shift in the profile of patients in need of artificial hearts to a higher risk group. More...
Researchers looked at the clinical records of 131 consecutive recipients of a LVAD as a bridge-to-transplantation, and found that despite the high-risk status of the patients, the overall mortality rate remained low at 50%. These results could have implications for the funding of artificial heart programs whereby more patients in the high-risk category would be candidates for mechanical assistance.

"The results continue to emphasize that patient selection is the predominant criteria for success in artificial heart programs, but that high-risk patients can be helped in experienced centers,” noted author Dr. Vivec Rao, surgical director of heart transplantation and mechanical circulatory assistance at the Toronto General Hospital.




Related Links:
Toronto General Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.